BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17330844)

  • 1. Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands.
    Louwman MW; Vriezen M; van Beek MW; Nolthenius-Puylaert MC; van der Sangen MJ; Roumen RM; Kiemeney LA; Coebergh JW
    Int J Cancer; 2007 Jul; 121(1):127-35. PubMed ID: 17330844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection method and breast carcinoma histology.
    Newcomer LM; Newcomb PA; Trentham-Dietz A; Storer BE; Yasui Y; Daling JR; Potter JD
    Cancer; 2002 Aug; 95(3):470-7. PubMed ID: 12209738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer.
    Berg JW; Hutter RV
    Cancer; 1995 Jan; 75(1 Suppl):257-69. PubMed ID: 8001000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Chu KC; Chang S; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands.
    Louwman WJ; Voogd AC; van Dijck JA; Nieuwenhuijzen GA; Ribot J; Pruijt JF; Coebergh JW
    Cancer Causes Control; 2008 Feb; 19(1):97-106. PubMed ID: 18038250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
    Christiansen P; Bjerre K; Ejlertsen B; Jensen MB; Rasmussen BB; Lænkholm AV; Kroman N; Ewertz M; Offersen B; Toftdahl DB; Møller S; Mouridsen HT;
    J Natl Cancer Inst; 2011 Sep; 103(18):1363-72. PubMed ID: 21881042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics.
    Nagao T; Kinoshita T; Hojo T; Tsuda H; Tamura K; Fujiwara Y
    Breast; 2012 Jun; 21(3):289-95. PubMed ID: 22277312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway.
    Albrektsen G; Heuch I; Thoresen SØ
    BMC Cancer; 2010 May; 10():226. PubMed ID: 20492657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Pfeiffer RM; Dores GM; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1899-905. PubMed ID: 17035397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands.
    Siesling S; Tjan-Heijnen VC; de Roos M; Snel Y; van Dalen T; Wouters MW; Struikmans H; van der Hoeven JJ; Maduro JH; Visser O
    Breast Cancer Res Treat; 2014 Aug; 147(1):177-84. PubMed ID: 25106659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
    Vo T; Xing Y; Meric-Bernstam F; Mirza N; Vlastos G; Symmans WF; Perkins GH; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Akins JS; Hunt KK
    Am J Surg; 2007 Oct; 194(4):527-31. PubMed ID: 17826073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
    Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age distribution of histologic types of breast carcinoma.
    Stalsberg H; Thomas DB
    Int J Cancer; 1993 Apr; 54(1):1-7. PubMed ID: 8478135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of breast cancer: experience at Lady Reading Hospital, Peshawar.
    Naeem M; Khan N; Aman Z; Nasir A; Samad A; Khattak A
    J Ayub Med Coll Abbottabad; 2008; 20(4):22-5. PubMed ID: 19999196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alterations of stage distribution for breast cancer since the implementation of national screening program in the Netherlands during 1989-1995].
    van Dijck JA; Hendriks JH; Holland R; Schouten LJ; Verbeek AL
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1119-24. PubMed ID: 10876707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute.
    Anderson WF; Devesa SS
    Cancer; 2005 Oct; 104(8):1733-41. PubMed ID: 16138363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
    Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
    Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.